AVOID 发表于 2025-3-27 00:23:04

http://reply.papertrans.cn/83/8285/828469/828469_31.png

Forsake 发表于 2025-3-27 02:41:17

http://reply.papertrans.cn/83/8285/828469/828469_32.png

Paleontology 发表于 2025-3-27 05:24:57

Pathophysiology: Metabolic Alterations and Risk Factorsght be insulin resistance and impaired glucose metabolism. As resistant hypertension could be further aggravated through unhealthy lifestyle and neglect of drug intake, it is common to see patients with less healthy lifestyle and worse psychosocial conditions also to have difficult-to-treat hyperten

affinity 发表于 2025-3-27 12:56:26

http://reply.papertrans.cn/83/8285/828469/828469_34.png

黑豹 发表于 2025-3-27 14:13:07

Resistant Hypertension: Cost-Benefit Considerationson of costs and benefits, including cost-effectiveness analysis, cost-utility analysis, which takes into account both the length and the quality of life, and cost-benefit analysis in which both the costs and the outcome (benefit) are measured in monetary terms. Cost-effectiveness and, to some extent

无辜 发表于 2025-3-27 18:52:13

http://reply.papertrans.cn/83/8285/828469/828469_36.png

记忆 发表于 2025-3-27 23:08:40

Book 2013disorder is of great current interest and importance for public health, being a common clinical problem faced by both primary care clinicians and specialists. Furthermore, as older age and obesity are among the strongest risk factors for uncontrolled hypertension, the incidence of resistant hyperten

猜忌 发表于 2025-3-28 05:29:36

http://reply.papertrans.cn/83/8285/828469/828469_38.png

stressors 发表于 2025-3-28 07:39:34

http://reply.papertrans.cn/83/8285/828469/828469_39.png

浓缩 发表于 2025-3-28 10:53:02

http://reply.papertrans.cn/83/8285/828469/828469_40.png
页: 1 2 3 [4] 5 6 7
查看完整版本: Titlebook: Resistant Hypertension; Epidemiology, Pathop Giuseppe Mancia Book 2013 Springer-Verlag Italia 2013 Antihypertensive drugs.Cardiovascular ri